Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
1.98 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 322.399 | 574.962 | 632.138 | 551.272 | 236.184 | 24.7 | 21.866 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 322.399 | 574.962 | 632.138 | 551.272 | 236.184 | 24.7 | 21.866 |
| Net Receivables
| 38.52 | 55.723 | 146.814 | 117.512 | 51.018 | 18.03 | 15.991 |
| Inventory
| 50.082 | 51.397 | 43.152 | 51.557 | 33.301 | 14.202 | 14.308 |
| Other Current Assets
| 18.145 | 17.83 | 25.798 | 19.698 | 11.095 | 3.62 | 1.637 |
| Total Current Assets
| 429.146 | 699.912 | 847.902 | 740.039 | 331.598 | 60.552 | 53.802 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 217.025 | 222.646 | 116.59 | 46.332 | 101.305 | 94.311 | 42.578 |
| Goodwill
| 159.878 | 326.029 | 283.668 | 152.766 | 224.275 | 224.275 | 224.275 |
| Intangible Assets
| 194.957 | 220.987 | 216.663 | 117.571 | 177.656 | 197.853 | 218.127 |
| Goodwill and Intangible Assets
| 354.835 | 547.016 | 500.331 | 270.337 | 401.931 | 422.128 | 442.402 |
| Long Term Investments
| 0 | 8.559 | 11.362 | 0.541 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 765.799 | 808.117 | 431.699 | 0 | 0 |
| Other Non-Current Assets
| 7.238 | 9.317 | 40.331 | 52.91 | 4.158 | 0.805 | 0.894 |
| Total Non-Current Assets
| 579.098 | 787.538 | 1,434.413 | 1,178.237 | 939.093 | 517.244 | 485.874 |
| Total Assets
| 1,008.244 | 1,487.45 | 2,282.315 | 1,918.276 | 1,270.691 | 577.796 | 539.676 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 11.957 | 10.729 | 5.991 | 8.154 | 2.985 | 7.478 | 3.604 |
| Short Term Debt
| 6.232 | 12.853 | 11.709 | 9.722 | 10.627 | 2.5 | 2.5 |
| Tax Payables
| 0.779 | 1.001 | 1.029 | 1.398 | 2.896 | 3.03 | 2.074 |
| Deferred Revenue
| 3.285 | 3.36 | 3.088 | 10.211 | 78.061 | 0.841 | 1.087 |
| Other Current Liabilities
| 34.718 | 59.525 | 88.327 | 64.292 | 40.836 | 15.713 | 26.654 |
| Total Current Liabilities
| 56.971 | 87.468 | 110.144 | 93.777 | 130.778 | 29.562 | 35.919 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 290.492 | 598.114 | 573.553 | 565.497 | 584.781 | 387.702 | 337.389 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 389.546 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 8.609 | 14.697 | 15.856 |
| Other Non-Current Liabilities
| 83.572 | 11.984 | 693.375 | 713.641 | 391.777 | 1.208 | 2.496 |
| Total Non-Current Liabilities
| 374.064 | 610.098 | 1,266.928 | 1,279.138 | 985.167 | 403.607 | 355.741 |
| Total Liabilities
| 431.035 | 697.566 | 1,377.072 | 1,372.915 | 1,115.945 | 433.169 | 391.66 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 2.527 | 2.513 | 2.554 | 2.552 | 2.576 | 183.91 | 182.809 |
| Retained Earnings
| 140.891 | 285.737 | 404.766 | 184.561 | 0.854 | -42.381 | -38.237 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0 | 0 | -0.044 | -0.133 | -0.167 |
| Other Total Stockholders Equity
| 181.874 | 128.503 | 137.898 | 128.386 | 85.125 | 0 | 0 |
| Total Shareholders Equity
| 325.292 | 416.753 | 545.218 | 315.499 | 88.511 | 141.396 | 144.405 |
| Total Equity
| 577.209 | 789.884 | 905.243 | 545.361 | 154.746 | 144.627 | 148.016 |
| Total Liabilities & Shareholders Equity
| 1,008.244 | 1,487.45 | 2,282.315 | 1,918.276 | 1,270.691 | 577.796 | 539.676 |